Global healthcare logistics QuickSTAT specializes in time- and temperature-sensitive logistics for pharma and biotech, with coverage in more than 150 countries. This breadth suggests opportunities to upsell end-to-end global cold chain services to expanding biopharma manufacturers and CROs seeking reliable international supply chains.

Life cycle focus The company supports the full product life-cycle from R&D to commercialization, including clinical trial logistics and direct-to-patient supply chains. This creates cross-sell potential across trial sponsors, CROs, and established pharma brands pursuing integrated logistics across development stages.

Specialized capabilities Expert handling of delicate therapies, cell and gene therapies, organs, tissue, and blood positions QuickSTAT for high-value, compliance-driven shipments. Target opportunities include gene therapy developers, organ/tissue banks, and hospitals requiring specialized transit solutions.

Technology edge Powered by advanced software like QuickOnline 2.0, the firm emphasizes tech-enabled visibility and control. This can be leveraged in conversations with mid-market biotech companies and clinical trial groups seeking robust tracking, data integrity, and real-time monitoring.

Emerging growth potential With a revenue range of 10–25 million and a focused niche in healthcare logistics, QuickSTAT is positioned to scale through partnerships with mid-sized pharma, CROs, and logistics consolidators seeking differentiated specialty services to compete with larger providers.